Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06552247Not ApplicableNot Yet Recruiting

Glaucoma Algorithm Validation Study in African Population - the MAGIC Study

Role: lead

NCT05875090Not ApplicableEnrolling By Invitation

Glaucoma Portugal Screening Trial

Role: lead

NCT05473949Not ApplicableCompleted

Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients.

Role: lead

NCT05355376Completed

Colorectal Surgical Site Infection

Role: lead

NCT04370808Completed

VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection

Role: collaborator

All 5 trials loaded